United Therapeutics (UTH) Q4 2025 Earnings Report
CH:UTH Q4 2025 EPS Results
- Actual EPS
- CHF 6.34
- Consensus EPS
- CHF 5.87
- Beat/Miss
- Beat by +CHF 0.47
- One Year Ago EPS
- CHF 5.10
CH:UTH Q4 2025 Revenue Results
- Actual Revenue
- CHF 651.00M
- Expected Revenue
- CHF 669.85M
- Beat/Miss
- Missed by -CHF 18.85M
- YoY Revenue Growth
- +7.38%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/25/2026
- Time
- Before Open
- Conference Call
- Wednesday, February 25, 2026
CH:UTH Upcoming Earnings
United Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
CH:UTH Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 4.95- | 5.9 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 5.655.99 | 5.28 | 13.42% (+0.71) | |
| May 06, 2026 | 2026 (Q1) | 5.774.79 | 5.46 | -12.22% (-0.67) | |
| Feb 25, 2026 | 2025 (Q4) | 5.876.34 | 5.1 | 24.39% (+1.24) | |
| Oct 29, 2025 | 2025 (Q3) | 6.035.90 | 5.26 | 12.05% (+0.63) | |
| Jul 30, 2025 | 2025 (Q2) | 6.015.28 | 4.82 | 9.57% (+0.46) | |
| Apr 30, 2025 | 2025 (Q1) | 5.525.46 | 5.08 | 7.46% (+0.38) | |
| Feb 26, 2025 | 2024 (Q4) | 5.275.10 | 3.59 | 41.97% (+1.51) | |
| Oct 30, 2024 | 2024 (Q3) | 5.375.26 | 4.43 | 18.77% (+0.83) | |
| Jul 31, 2024 | 2024 (Q2) | 5.364.82 | 4.32 | 11.64% (+0.50) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed